PhenoPath, PLLC

Diagnoses you can count on®

PhenoPath, PLLC is a physician-owned specialty pathology practice and reference laboratory providing diagnostic and contract research services to pathology and oncology practices, hospitals, biopharmaceutical companies and research institutions in the U.S., Canada and around the world.

PhenoPath’s test menu includes a broad array of state-of-the-art immunohistochemistry, flow cytometry, fluorescence in situ hybridization and molecular assays as well as chromosome analysis.


Latest News

  • Steven H. Swerdlow, MD: Update on the WHO Classification of Hematolymphoid Neoplasms

    Steven H. Swerdlow, MD will present: “Great Expectations? Updating the WHO Classification...

    Read More »
  • PhenoUpdate (September 2014)

    New Tests / Tests Under Development / Important Test Utilization and Reporting News / Etc.

    Read More »
  • Phenomena Volume 17 No. 3 (Summer 2014)

    Lynch Syndrome Algorithm / 1q21+1p21 in Multiple Myeloma / PhenoPath Introduces Multiplex Assays / AJSP publication / Etc.

    Read More »

PhenoPath, PLLC

About PhenoPath


Medical Staff

Executive Staff

Licensing & Accreditation


Test Menu


Diagnostic Services

Clinical Setting

Educational Media

Contact Diagnostic Services

CRO Services

Clinical Trial Services

R & D Services



Contact CRO Services

News & Info

Company News



Upcoming Events

Contact Us

Dept. Inquiries

Submit a Case

Order Supplies